'Hodgkin lymphoma' diaporamas de présentation

Lymphoma

Lymphoma. Farjah Hassan AlGahtani Assistant Professor, Consultant Hematology Director of Transfusion Medicine and Blood Bank. Overview. Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma. Conceptualizing lymphoma.

1.03k views • 67 slides

BIOE 301

BIOE 301. Lecture Twelve. Review of Lecture 11. Belmont Report Respect for persons Beneficence Justice Process of informed consent. Four Questions. What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems?

902 views • 66 slides

Updates in Aggressive B-Cell Non-Hodgkin Lymphoma

Updates in Aggressive B-Cell Non-Hodgkin Lymphoma. Program Goals. Abbreviations. Abbreviations (cont). Abbreviations (cont). Abbreviations (cont). References. References (cont). References (cont). References (cont). References (cont). References (cont). References (cont).

961 views • 65 slides

The benefit and Risks of Nutritional Supplements

The benefit and Risks of Nutritional Supplements . Peiying Yang, Ph.D. Department of General Oncology The University of Texas M.D. Anderson Cancer Center. Dietary Supplements. Congress defined the term "dietary supplement" in the Dietary Supplement Health and Education Act (DSHEA)

886 views • 59 slides

Salivary Gland

Salivary Gland. Tumors. Classification. Tumors Adenoma (Benign) Carcinomas (malignant) Others. Adenoma (Benign). Pelomorphic adenoma Warthin tumor Basal cell adenoma Oncocytoma Ductal papilomas Canalicular adenoma Sabaceous adenoma Cyst adenoma. Carcinoma (malignant).

1.12k views • 56 slides

CANCER EPIDEMIOLOGY IN CROATIA

707 views • 53 slides

Pathology 6 White blood cell and lymph node disorders (1)

Pathology 6 White blood cell and lymph node disorders (1). Toxic changes in neutrophils include all the following, except: Cytoplasmic basophilia Large basophilic granules Hypersegmentation Cytoplasmic vacuoles Dohle bodies. Large granular lymphoma is associated with Neutropenia

1.13k views • 46 slides

Gastroenterology, Volume 143, Issue 4, October 2012, Pages e13-e14 By:azadbakht

Se cond Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 Years. Gastroenterology, Volume 143, Issue 4, October 2012, Pages e13-e14 By:azadbakht.

655 views • 45 slides

Cancer Epidemiology

Cancer Epidemiology. Introduction. Cancer. One of the most important issues of public health in Iran & all the world (now) Growing importance Third cause of death in Iran Second large group of non-communicable diseases in Iran Every year at least 9 million new cases

616 views • 44 slides

K. Pavenski , MD FRCPC Transfusion Medicine Resident, McMaster University TMR Journal Club

Risk of Cancer After Blood Transfusion From Donors with Subclinical Cancer: A Retrospective Cohort Study. K. Pavenski , MD FRCPC Transfusion Medicine Resident, McMaster University TMR Journal Club June 20, 2007. Introduction. Can blood transfusion transmit cancer? YES

623 views • 37 slides

Lymphoma

669 views • 36 slides

Lymphoma s

Lymphoma s. S. Sami Kart?, MD, Prof. Conceptualizing lymphoma. neoplasms of lymphoid origin, typically causing lymphadenopathy. ALL. CLL. Lymphomas. MM. Neutrophils. AML. Myeloproliferative disorders. Myeloid progenitor. Eosinophils. Hematopoietic stem cell. Basophils. Monocytes.

525 views • 34 slides

Hodgkin lymphoma

Hodgkin lymphoma. Histologic subtypes: - Nodular sclerosing - Mixed cellularity - Lymphocyte predominance Lymphocyte depleted new category: - Lymphocyte rich. Radiotherapy Chemiotherapy A B M T. Hodgkin lymphoma. Radiotherapy: Involved field radiotherapy (IFRT): 35 to 44 Gy

711 views • 33 slides

PCBs in Schools Risk e Learning Webinar April 28, 2014

Evaluating Health Risks from Inhaled PCBs: Research Needs to Address Uncertainty Geniece M. Lehmann, Ph.D. (U.S. EPA/ORD). PCBs in Schools Risk e Learning Webinar April 28, 2014. Overview. History of U.S. interest in health risks of PCB inhalation

442 views • 29 slides

Hodgkin lymphoma

Hodgkin lymphoma. Clinical presentation and treatment. Hodgkin lymphoma. Malignant cell is a B lymphocyte Enlarged lymph nodes important clinical sign Thus: Confusion! Patients Students

656 views • 24 slides

Bradford Hoppe MD, MPH William Hartsell, MD

Bradford Hoppe MD, MPH William Hartsell, MD. Proton Therapy Patterns-of-Care and Early Outcomes for Hodgkin Lymphoma: Results from the Proton Collaborative Group Registry. Background. Hodgkin lymphoma survivors are at the highest risk of late complications among cancer survivors. CCSS-.

408 views • 18 slides

Presentation to the Centers for Disease Control and Prevention May 2008

Presentation to the Centers for Disease Control and Prevention May 2008. Overview. Organizational Background Project Goals Partnerships Evaluation Activities Memorable Moment/Highlight. Our mission is to eradicate lymphoma and serve those touched by this disease.

316 views • 18 slides

Current Standard of Care

Adcetris (Brentuximab Vedotin): A New Treatment Strategy for Relapsed or Refractory Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (ALCL). Current Standard of Care. Approximately 5 -10% of HL patients are refractory to initial treatment

449 views • 12 slides

2.21k views • 4 slides

Borchmann, P. et al. ( 2012) State of the art in the treatment of Hodgkin lymphoma

Figure 4 Study designs of the GITIL HD0607 trial and the GHSG HD18 (NCT00515554) trial for patients with newly diagnosed advanced-stage HL. Borchmann, P. et al. ( 2012) State of the art in the treatment of Hodgkin lymphoma Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.91.

309 views • 1 slides